• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Studies on the susceptibility to coronary artery sclerosis in patients with familial hypercholesterolemia

Research Project

Project/Area Number 03454222
Research Category

Grant-in-Aid for General Scientific Research (B)

Allocation TypeSingle-year Grants
Research Field 内科学一般
Research InstitutionOkinaka Memorial Institute for Medical Research

Principal Investigator

MURASE Toshio  Okinaka Memorial Institute for Medical Research, 主任研究員 (60107612)

Co-Investigator(Kenkyū-buntansha) TSUKADA Masayasu  冲中記念成人病研究所, 主任研究員 (90072595)
SIKI Akira  冲中記念成人病研究所, 主任研究員
OKUBO Minoru  冲中記念成人病研究所, 研究員 (60241238)
KOBAYASHI Tetsuro  冲中記念成人病研究所, 研究員 (30113442)
Project Period (FY) 1991 – 1993
Project Status Completed (Fiscal Year 1993)
Budget Amount *help
¥5,900,000 (Direct Cost: ¥5,900,000)
Fiscal Year 1993: ¥2,100,000 (Direct Cost: ¥2,100,000)
Fiscal Year 1992: ¥1,800,000 (Direct Cost: ¥1,800,000)
Fiscal Year 1991: ¥2,000,000 (Direct Cost: ¥2,000,000)
KeywordsFamilial hypercholesterolemia / Coronary artery sclerosis / Serum cholesterol values / HDL-cholesterol / Lipoprotein (a) / Blood coagulation-fibrinolysis / HLA antigen / LDL receptor / 冠動脈硬化 / Lp(a) / LDLレセプター遺伝子変異 / 家族性高コレステロ-ル血症
Research Abstract

We have studied the factors responsible for the development of coronary artery sclerosis in adult patients with familial hypercholesterolemia (FH). The results are as follows :
1. Forty subjects (21%) had coronary heart disease (CHD). In many subjects (17/40cases), the disease developed before the age of 50 yr.
2. No sex difference was observed for the development of CHD.
3. Frequency of CHD among family members in subjects with CHD did not differ from that in subjects without CHD.
4. Subjects with serum cholesterol levels of more than 400mg/dl showed higheer frequency of CHD.Subjects with CHD had low HDL-cholesterol levels.
5. Many FH subjects had elevated serum levels of Lp(a). However, there was no difference in serum Lp(a) between subjects with and without CHD.
6. No abnormalities were observed in blood coagulation-fibrinolysis parameters in FH subjects.
7. No specific HLA antigen was related to the development of CHD in FH subjects.
8. One female subject who had CHD in her age of 37 yr was shown to be a new mutant in the LDL receptor gene (deletion of exons 9 & 10). Whether any specific gene mutation relates to the early development of CHD remains to be assessed in future studies.

Report

(4 results)
  • 1993 Annual Research Report   Final Research Report Summary
  • 1992 Annual Research Report
  • 1991 Annual Research Report
  • Research Products

    (25 results)

All Other

All Publications (25 results)

  • [Publications] Gotoda T,Murase T et al.: "Heterogenous mutations in the human lipoprotein lipase in patients with familial lipoprotein lipase deficiency" Journal of Clinical Investigation. 88. 1856-1864 (1991)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Hiraga T,Harada K,Kobayashi T,Murase T: "Reduction of serum lipoprotein(a) using estrogen in a man with familial hypercholesterolemia" JAMA. 267. 2328 (1992)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Hiraga T,Okubo M,Kobayashi T,Nakanishi K,Sugimoto T,Murase T: "Serum lipoprotein(a) levels differ in different phenotypes of primary hyperlipoproteinemia" Metabolism. 42. 1327-1330 (1993)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Inoue S,Satoh S,Tanaka K,Takamura Y,Murase T: "Determinants of fasting hypertriglyceridemia in ventromedial hypothalamic obesity in rats" American Journal of Physiology. 265. R786-791 (1993)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Tsutsumi K,Inoue Y,Shima A,Iwasaki K,Kawamura M,Murase T: "The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholestero,and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis" Journal of Clinical Investigation. 92. 411-417 (1993)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Gotoda T, Yamada N, Kawamura M, Kozaki K, Mori N, Ishibashi S, Shimano H, Takaku F, Yazaki Y, Furuichi Y and Murase T: "Heterogenous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency" J Clin Invest. 88. 1856-1864 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Hiraga T, Harada K, Kobayashi T and Murase T: "Reduction of serum lipoprotein (a) using estrogen in a man with familial hypercholesterolemia" JAMA. 267. 2328 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Hiraga T, Okubo M, Kobayashi T, Nakanishi K, SugimotoT and Murase T: "Serum lipoprotein (a) levels differ in different phenotypes of primary hyperlipoproteinemia" Metabolism. 42. 1327-1330 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Inoue S, Satoh S,Yanaka K, Takamura Y and Murase T: "Determinants of fasting hypertriglyceridemia in ventromedial hypothalamic obesity in rats" Amer J Physiol. 265. R786-791 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Tsutsumi K, Inoue Y, Shima A, Iwasaki K, Kawamura M and Murase T: "The novel compound NO-1886 increased lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis" J Clin Invest. 92. 411-417 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Hiraga T et al.: "Serum lipoprotein(a) levels differ in different phenotypes of primary hyperlipoproteinemia" Metabolism. 42. 1327-1330 (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] Inoue S et al.: "Determinants of fasting hypertriglyceridemia in vantromedial hypothalamic obesity in rats" American Journal of Physiology. 265. R786-791 (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] Tsutsumi K et al.: "The novel compound NO‐1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol," Journal of Clinical Investigation. 92. 411-417 (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] Yamazaki T et al.: "Prediction of the severity of coronary artery disease by measurement of lipoprotein(a)." Coronary Art Dis. 3. 57-60 (1992)

    • Related Report
      1992 Annual Research Report
  • [Publications] Kobayashi T et al.: "Relationship between islet amyloid polypeptide(IAPP)deposition and insulin response and β-cell volume in diabetes mellitus." Diabetes Res & Clin Pract. 15. 15-16 (1992)

    • Related Report
      1992 Annual Research Report
  • [Publications] Gotoda T et al.: "Detection of three separate DNA polymorphisms in the human lipoprotein lipase gene by amplification and restriction endonuclease digestion." J Lipid Res. 33. 1067-1072 (1992)

    • Related Report
      1992 Annual Research Report
  • [Publications] Hiraga T et al.: "Reduction of serum lipoprotein(a) using estrogen in a man with familal hypercholesterolemia." JAMA. 267. 2328- (1992)

    • Related Report
      1992 Annual Research Report
  • [Publications] Hiraga T et al.: "Serum lipoprotein(a) levels differ in different phenotypes of primary hyperlipoproteinemia." Metabolism.

    • Related Report
      1992 Annual Research Report
  • [Publications] Tsutsumi K et al.: "The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of HDL-cholesterol,and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis." J Clin Invest.

    • Related Report
      1992 Annual Research Report
  • [Publications] Kawakami,M.et al.: "Suppression of lipoprotein lipase in 3T3-L1 cells by a mediator produced by SEKI melanoma,a cachexia-inducing human melanoma cell line." J.Biochem.109. 78-82 (1991)

    • Related Report
      1991 Annual Research Report
  • [Publications] Murase,T.et al.: "Does chylomicronemia cause atherosclerosis?" Tohoku J.Exp.Med.163. 129-134 (1991)

    • Related Report
      1991 Annual Research Report
  • [Publications] Shimano,H.et al.: "Oxidation-labile subfraction of human plasma low density lipoprotein isolated by ion-exchange chromatography." J.Lipid Res.32. 763-773 (1991)

    • Related Report
      1991 Annual Research Report
  • [Publications] Gotoda,T.et al.: "Differential phenotypic expression by three mutant alleles in familial lecithin:cholesterol acyltransferase deficiency." Lancet. 338. 778-781 (1991)

    • Related Report
      1991 Annual Research Report
  • [Publications] Gotoda,T.et al.: "Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency." J.Clin.Invest.88. 1856-1864 (1991)

    • Related Report
      1991 Annual Research Report
  • [Publications] Gotoda,T.et al.: "Occurrence of multiple aberrantly spliced mRNAs upon a donor splice site mutation that causes familial lipoprotein lipase deficiency." J.Biol.Chem.266. 24757-24762 (1991)

    • Related Report
      1991 Annual Research Report

URL: 

Published: 1991-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi